Docetaxel is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumor including breast and lung cancer.Docetaxel was patented in 1986 and approved for medical use in 1995.
SynZeal offers all Docetaxel related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Docetaxel related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.
